This whitepaper, produced by Novasep, addresses the numerous justifications for switching from batch to continuous chromatography. Among them, the rising demand of biologics suggests reduced processing and labor costs, footprint reduction, flexibility increase, more stringent requirements for controlled, more consistent and improved quality; and most importantly, the requirement for higher productivity and therefore overall manufacturing cost reduction. Learn More